ARCA is a 5′ cap analog that functions as an anti-reverse cap analog. ARCA ensures that the cap is connected to the 5′ end of mRNA in the correct orientation during in vitro transcription. By introducing a methyl group at the 3′-OH position of m7G, ARCA ensures correct directional attachment to the 5′ end of mRNA and prevents reverse incorporation during in vitro transcription. ARCA enhances mRNA translation efficiency and stability. ARCA can be used for research on cancer, infectious diseases and mRNA vaccines[1-4].
References:
[1] Sun H, Song Y, Chen F, et al. An ArcA-Modulated Small RNA in Pathogenic Escherichia coli K1. Front Microbiol. 2020 Nov 23;11:574833.
[2] Fu T, Fan Z, Chen Y, et al. ArcA modulates multidrug resistance and compound susceptibility in Klebsiella pneumoniae through ArcB-independent regulation of the SMR efflux pump kpnEF. Microbiol Spectr. 2025 Nov 4;13(11):e0149925.
[3] Kowalska J, Wypijewska del Nogal A, et al. Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes. Nucleic Acids Res. 2014;42(16):10245-64.
[4] Bednarczyk M, Peters JK, Kasprzyk R, et al. Fluorescence-Based Activity Screening Assay Reveals Small Molecule Inhibitors of Vaccinia Virus mRNA Decapping Enzyme D9. ACS Chem Biol. 2022 Jun 17;17(6):1460-1471.
















